Liquid Biopsies Could Predict Survival Odds for Patients with Metastatic Cancer

November 21, 2022


Read time:

5-15 mins
Vein DNA Helix Blood Cell
Presented by Health Lab

As cancers grow and potentially spread to new areas of the body, tests like liquid biopsies have become standard practice for some cancers, particularly those with drugs that treat the DNA mutation. Liquid biopsies are analyses of the amount of DNA present and whether any potential mutations exist, and this test is crucial for helping providers choose a treatment method. Zachery Reichert, M.D., Ph.D., a clinical associate professor, discusses the impact such tests can have and the development of tumor fractioning to aid in the cause.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.